|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2025
vol. 78 abstract:
Original paper
Comparative effectiveness of intraoral vs. combined intraoral/extraoral photobiomodulation for oral chemotoxicity prophylaxis: a pilot study
Marwa Khalil
1
,
Omar Hamadah
1
,
Maher Saifo
2
J Stoma 2025; 78, 4: 278-284
Online publish date: 2025/11/04
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
Conventional chemotherapy frequently induces debilitating oral side effects, including mucositis, xerostomia, and dysgeusia, which significantly impair patients’ quality of life and treatment adherence. Photobiomodulation (PBM) has emerged as a promising therapeutic strategy for mitigating chemotherapy-induced oral toxicities. However, inconsistent irradiation parameters and absence of standardized protocols hinder its widespread clinical adoption. Objectives This pilot study evaluated the impact of PBM on oral health through comparative analysis of sole intraoral 635 nm wavelength delivery versus a dual-modality approach incorporating both intraoral 635 nm and extraoral 980 nm near-infrared irradiation. Material and methods This study enrolled 45 participants stratified into three demographically and clinically matched cohorts. Intervention groups were structured as follows: group 1 received standard oral care, group 2 added intraoral PBM (635 nm diode laser), and group 3 combined intraoral (635 nm) and extraoral (980 nm) PBM, with oral health outcomes assessed using the validated Oral Assessment Guide developed by Eilers (1988). Results Both laser-treated groups showed significant preventive advantages (p < 0.001) at one week and two weeks follow-ups compared with the control group. These protective effects were observed in swallowing, lips, tongue, mucosa, saliva, and gums. The clinical outcomes demonstrated comparable efficacy between the intraoral red laser and combined intraoral/extraoral infrared laser treatment modalities, except in swallowing, where the combined laser approach was superior. Conclusions PBM therapy, whether intraoral alone or combined intraoral and extraoral, effectively reduces chemotherapy-induced oral complications. The combined laser protocol demonstrated enhanced benefits in swallowing-related outcomes, emphasizing its potential as a valuable adjunctive therapy. keywords:
photobiomodulation, chemotherapy, saliva, mucosa, swallowing |